Taken together, our results suggest that compound 9 exerts an antiangiogenic activity via the dual downregulation of VEGF/VEGFR2-mediated signaling in ECs and HIF-1α/VEGF expression in tumor cells. This evidence concerns the gene KDR and neoplasm.